Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

LOXAPINE SUCCINATE: LATEST NEUROLEPTIC APPROVED BY FDA

Prescribing Guidelines For Maximum Benefit

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    LOXAPINE SUCCINATE: LATEST NEUROLEPTIC APPROVED BY FDA. Inpharma Wkly. 53, 16–17 (1976). https://doi.org/10.1007/BF03288722

    Download citation

    Keywords

    • Loxapine
    • Drug Holiday
    • Anti Parkinson Drug
    • International Collaborative Study
    • Chronic Schizophrenic